Breaking News Instant updates and real-time market news.

RGEN

Repligen

$43.22

-0.54 (-1.23%)

, GE

General Electric

$25.09

-0.025 (-0.10%)

10:28
09/26/17
09/26
10:28
09/26/17
10:28

GE launch to weight on Repligen's valuation, says Jefferies

GE Healthcare (GE), Repligen's largest customer, announced plans to launch a new Protein A resin in the first half of 2018 that will not utilize Repligen as the manufacturer of the associated protein A ligand, Jefferies analyst Brandon Couillard tells investors in a research note. Repligen shares are down 12%, or $5.10, to $38.12 in morning trading. While the near-term financial impact appears negligible to Repligen, the long-term implications are negative, Couillard contends. He believes GE's move to in-source protein A ligands "diminishes the value" of Repligen's "near-monopoly position" and could weigh on its "premium" multiple. The analyst has a Hold rating on Repligen with a $40 price target.

RGEN

Repligen

$43.22

-0.54 (-1.23%)

GE

General Electric

$25.09

-0.025 (-0.10%)

  • 29

    Sep

  • 02

    Oct

  • 30

    Nov

RGEN Repligen
$43.22

-0.54 (-1.23%)

07/21/17
WBLR
07/21/17
INITIATION
WBLR
Outperform
Repligen initiated with an Outperform at William Blair
William Blair analyst Amanda Murphy started Repligen with an Outperform rating.
06/23/17
JANY
06/23/17
NO CHANGE
Target $47
JANY
Buy
Repligen price target raised to $47 from $42 at Janney Capital
Janney Capital analyst Paul Knight raised his fair value estimate on Repligen to $47 from $42 following the company's agreement to acquire privately-held Spectrum, which the company said is expected to accelerate the growth of its filtration business. Knight keeps a Buy rating on Repligen shares.
04/24/17
04/24/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Herbalife (HLF) initiated with Buy rating at Tigress Financial. 2. Winnebago (WGO) initiated with a Buy at CL King. 3. Visteon (VC) initiated with an Equal Weight at Morgan Stanley. 4. Repligen (RGEN) initiated with an Equal-Weight at First Analysis. 5. Ritchie Bros. (RBA) assumed with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/24/17
FANA
04/24/17
INITIATION
Target $40
FANA
Equal-Weight
Repligen initiated with an Equal-Weight at First Analysis
First Analysis initiated Repligen with an Equal Weight and a $40 price target.
GE General Electric
$25.09

-0.025 (-0.10%)

09/11/17
DBAB
09/11/17
NO CHANGE
Target $21
DBAB
Sell
Deutsche Bank cuts GE price target to $21 on 2018 estimate reduction
Deutsche Bank analyst John Inch cut his price target for General Electric shares to $21 from $24 after reducing his 2018 earnings estimate for the company to $1.55 from $1.85. His forecast now assumes weaker Power, reduced earnings benefit due to curtailed share repurchase, as well as a 5c drag from the adoption of ASU No. 2014-09. There could be further downside risk to estimates after management resets 2018 earnings in November, Inch tells investors in a research note. He notes his estimate does not include the potential adoption of other more conservative accounting practices, including a significantly higher tax rate. The analyst keeps a Sell rating on GE shares.
09/07/17
JPMS
09/07/17
NO CHANGE
Target $22
JPMS
Underweight
JPMorgan sees $24 as ceiling not floor for GE shares
In a research note titled "Preparing For The Fall: It's Worse Than We Think.", JPMorgan analyst C. Stephen Tusa says he remains negative on General Electric shares with a $22 price target and Underweight rating. The analyst now views $24 per share as a "ceiling as opposed to a floor prior," and a stock in the high teens as an "investable fair value." GE closed yesterday up 16c to $24.92. Tusa sees downside risk to his well below consensus estimates, and notes the Street is slowly approaching his numbers. GE's cash position is not inflecting, thus current levels are a run rate, not "depressed," Tusa writes. He sees a downside scenario in 2018 GAAP earnings per share to the $1.15-$1.20 range as a potential starting point, compared to current consensus of $1.70.
08/31/17
LEHM
08/31/17
INITIATION
Target $41
LEHM
Overweight
Baker Hughes initiated with an Overweight at Barclays
Barclays analyst J. David Anderson started Baker Hughes (BHGE) with an Overweight rating and $41 price target. The analyst believes the merger with GE (GE) goes a long way toward addressing some of the company's legacy issues around execution.
08/03/17
PIPR
08/03/17
NO CHANGE
Target $14
PIPR
Underweight
3D Systems reported disappointing results, says Piper Jaffray
Piper Jaffray analyst Troy Jensen says 3D Systems (DDD) last night reported disappointing results with weak printer sales being the primary factor in the revenue miss. The weak printer sales are directly correlated with increased competition from HP Inc. (HPQ), General Electric (GE) and others attacking 3D Systems' key product lines, Jensen tells investors in a post-earnings research note. He sees the company's second half of 2017 as "incrementally more challenging" and believes the stock's a "significant premium" to 3D printing peers is unwarranted. The analyst reiterates an Underweight rating on 3D Systems with a $14 price target.

TODAY'S FREE FLY STORIES

05:30
10/23/17
10/23
05:30
10/23/17
05:30
General news
FX Action: USD-JPY has remained settled under 114.00 »

FX Action: USD-JPY has…

NVS

Novartis

$85.74

-0.42 (-0.49%)

05:29
10/23/17
10/23
05:29
10/23/17
05:29
Hot Stocks
Novartis receives FDA Breakthrough Therapy Designation for Tafinlar/Mekinist »

Novartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

  • 08

    Nov

  • 13

    Nov

  • 30

    Nov

  • 04

    Dec

  • 17

    May

BA

Boeing

$264.75

5.71 (2.20%)

05:25
10/23/17
10/23
05:25
10/23/17
05:25
Hot Stocks
Boeing, Mitsubishi Heavy reach agreement on cost reduction for 787 production »

Boeing and Mitsubishi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

BAC

Bank of America

$27.17

0.59 (2.22%)

05:24
10/23/17
10/23
05:24
10/23/17
05:24
Hot Stocks
Merrill Lynch fined $45.5M in Britain for not reporting derivative transactions »

Bank of America's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ATHN

athenahealth

$126.04

9.63 (8.27%)

05:18
10/23/17
10/23
05:18
10/23/17
05:18
Upgrade
athenahealth rating change  »

athenahealth upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TATYY

Tate & Lyle

$33.23

-0.835 (-2.45%)

05:13
10/23/17
10/23
05:13
10/23/17
05:13
Upgrade
Tate & Lyle rating change  »

Tate & Lyle upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$48.37

0.24 (0.50%)

05:12
10/23/17
10/23
05:12
10/23/17
05:12
Downgrade
Rio Tinto rating change  »

Rio Tinto downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MELI

MercadoLibre

$235.73

-0.27 (-0.11%)

05:02
10/23/17
10/23
05:02
10/23/17
05:02
Recommendations
MercadoLibre analyst commentary  »

MercadoLibre price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$338.10

-4.32 (-1.26%)

04:59
10/23/17
10/23
04:59
10/23/17
04:59
Initiation
Biogen initiated  »

Biogen assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

CELG

Celgene

$121.33

-14.63 (-10.76%)

04:56
10/23/17
10/23
04:56
10/23/17
04:56
Downgrade
Celgene rating change  »

Celgene assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

04:55
10/23/17
10/23
04:55
10/23/17
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

ASOMY

ASOS

$74.28

1.5 (2.06%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
ASOS management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

04:55
10/23/17
10/23
04:55
10/23/17
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

04:55
10/23/17
10/23
04:55
10/23/17
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

PAY

Verifone

$20.06

0.06 (0.30%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
Verifone management to meet with Jefferies »

Meeting to be held in Las…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 14

    Dec

PLUG

Plug Power

$2.70

0.17 (6.72%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
Plug Power to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 16

    Nov

DDAIF

Daimler AG

$80.57

-1.11 (-1.36%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
Daimler AG management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

04:55
10/23/17
10/23
04:55
10/23/17
04:55
General news
Chicago Fed National Activity Index Level to be reported at 08:30 »

September Chicago Fed…

IVC

Invacare

$14.60

0.05 (0.34%)

04:55
10/23/17
10/23
04:55
10/23/17
04:55
Conference/Events
Invacare management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ALXN

Alexion

$139.02

-1.44 (-1.03%)

04:54
10/23/17
10/23
04:54
10/23/17
04:54
Initiation
Alexion initiated  »

Alexion assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 26

    Oct

  • 06

    Nov

BIVV

Bioverativ

$60.22

0.49 (0.82%)

04:52
10/23/17
10/23
04:52
10/23/17
04:52
Initiation
Bioverativ initiated  »

Bioverativ assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 06

    Nov

TSRO

Tesaro

$116.40

0.89 (0.77%)

04:50
10/23/17
10/23
04:50
10/23/17
04:50
Downgrade
Tesaro rating change  »

Tesaro assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

  • 08

    Nov

AMAG

Amag Pharmaceuticals

$15.60

-0.45 (-2.80%)

04:48
10/23/17
10/23
04:48
10/23/17
04:48
Initiation
Amag Pharmaceuticals initiated  »

Amag Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 02

    Feb

  • 14

    Feb

04:15
10/23/17
10/23
04:15
10/23/17
04:15
General news
FX Action: USD-CAD has remained underpinned »

FX Action: USD-CAD has…

03:05
10/23/17
10/23
03:05
10/23/17
03:05
General news
FX Update: The dollar has traded mixed »

FX Update: The dollar has…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.